These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2954584)

  • 21. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubilization and characterization of striatal dopamine receptors.
    Lew JY; Goldstein M
    J Neurochem; 1984 May; 42(5):1298-305. PubMed ID: 6707634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential adsorption of dopamine antagonist binding sites by fluphenazine-agarose.
    Fong JC
    Proc Natl Sci Counc Repub China B; 1986 Apr; 10(2):113-7. PubMed ID: 3749364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstitution of solubilised brain D2 dopamine receptors into phospholipid vesicles.
    Wheatley M; Strange PG
    FEBS Lett; 1984 Jan; 166(2):389-92. PubMed ID: 6229421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.
    Tam SW; Cook L
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5618-21. PubMed ID: 6147851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug potencies on partially purified brain D2 dopamine receptors.
    Madras BK; Seeman P
    J Neurochem; 1985 Mar; 44(3):856-61. PubMed ID: 2579201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D2 dopamine receptors in calf globus pallidus: agonist high- and low-affinity sites not regulated by guanine nucleotide.
    De Keyser J; De Backer JP; Convents A; Ebinger G; Vauquelin G
    J Neurochem; 1985 Sep; 45(3):977-9. PubMed ID: 2411862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the interactions of antiestrogens with pituitary and striatal dopamine receptors.
    Toney TW; Katzenellenbogen BS
    J Recept Res; 1987; 7(5):695-712. PubMed ID: 2958626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific phospholipid requirements for the solubilization and reconstitution of D-1 dopamine receptors from striatal membranes.
    Balen P; Kimura K; Sidhu A
    Biochemistry; 1994 Feb; 33(6):1539-44. PubMed ID: 8312274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D2 receptors photolabeled by iodo-azido-clebopride.
    Niznik HB; Dumbrille-Ross A; Guan JH; Neumeyer JL; Seeman P
    Neurosci Lett; 1985 Apr; 55(3):267-72. PubMed ID: 3159976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of the D2-dopamine receptor from bovine anterior pituitary.
    Senogles SE; Amlaiky N; Falardeau P; Caron MG
    J Biol Chem; 1988 Dec; 263(35):18996-9002. PubMed ID: 3143721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A; Seeman P
    Biochem Pharmacol; 1987 Jul; 36(13):2095-9. PubMed ID: 2955789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors.
    Rogue P; Zwiller J; Malviya AN; Vincendon G
    Biochem Int; 1990 Nov; 22(3):575-82. PubMed ID: 1981673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstitution of beta-adrenergic receptors in lipid vesicles: affinity chromatography-purified receptors confer catecholamine responsiveness on a heterologous adenylate cyclase system.
    Cerione RA; Strulovici B; Benovic JL; Strader CD; Caron MG; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):4899-903. PubMed ID: 6308659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.